Literature DB >> 17451496

Nonsteroidal anti-inflammatory drugs in cats: a review.

B Duncan X Lascelles1, Michael H Court, Elizabeth M Hardie, Sheilah A Robertson.   

Abstract

OBJECTIVE: To review the evidence regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in cats. DATABASES USED: PubMed, CAB abstracts.
CONCLUSIONS: Nonsteroidal anti-inflammatory drugs should be used with caution in cats because of their low capacity for hepatic glucuronidation, which is the major mechanism of metabolism and excretion for this category of drugs. However, the evidence presented supports the short-term use of carprofen, flunixin, ketoprofen, meloxicam and tolfenamic acid as analgesics in cats. There were no data to support the safe chronic use of NSAIDs in cats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451496     DOI: 10.1111/j.1467-2995.2006.00322.x

Source DB:  PubMed          Journal:  Vet Anaesth Analg        ISSN: 1467-2987            Impact factor:   1.648


  19 in total

1.  Effect of tolfenamic acid on canine cancer cell proliferation, specificity protein (sp) transcription factors, and sp-regulated proteins in canine osteosarcoma, mammary carcinoma, and melanoma cells.

Authors:  H Wilson; G Chadalapaka; I Jutooru; S Sheppard; C Pfent; S Safe
Journal:  J Vet Intern Med       Date:  2012-04-27       Impact factor: 3.333

2.  Perioperative analgesic use by Ontario veterinarians, 2012.

Authors:  Jessica Reimann; Cate Dewey; Shane W Bateman; Carolyn Kerr; Ron Johnson
Journal:  Can Vet J       Date:  2017-02       Impact factor: 1.008

3.  Efficacy and safety of 3 versus 5 days of meloxicam as an analgesic for feline onychectomy and sterilization.

Authors:  Walt Ingwersen; Ronald Fox; Gail Cunningham; Martha Winhall
Journal:  Can Vet J       Date:  2012-03       Impact factor: 1.008

4.  Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sandeep Sreevalsan; Satya Pathi; Kyounghyun Kim; Candy Chen; Lisa Crose; Corinne Linardic; Stephen Safe
Journal:  Int J Cancer       Date:  2012-08-03       Impact factor: 7.396

Review 5.  Administration of meloxicam to improve the welfare of mice in research: a systematic review (2000 - 2020).

Authors:  Ana Tada Fonseca Brasil Antiorio; Jilma Alemán-Laporte; Ana Paula Pauloni de Freitas; Pedro Kenzo Yamamoto; Luciana Cintra; Claudia Madalena Cabrera Mori
Journal:  Vet Res Commun       Date:  2022-01-06       Impact factor: 2.459

6.  Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.

Authors:  Sabitha Papineni; Sudhakar Chintharlapalli; Maen Abdelrahim; Syng-ook Lee; Robert Burghardt; Ala Abudayyeh; Cheryl Baker; Luis Herrera; Stephen Safe
Journal:  Carcinogenesis       Date:  2009-04-30       Impact factor: 4.944

Review 7.  Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms.

Authors:  Michael H Court
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-09       Impact factor: 2.093

8.  Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial.

Authors:  Cindy Speranza; Vincent Schmid; Jerome M Giraudel; Wolfgang Seewald; Jonathan N King
Journal:  BMC Vet Res       Date:  2015-03-26       Impact factor: 2.741

9.  Evaluation of oral robenacoxib for the treatment of postoperative pain and inflammation in cats: results of a randomized clinical trial.

Authors:  Stephen King; Elizabeth S Roberts; Linda M Roycroft; Jonathan N King
Journal:  ISRN Vet Sci       Date:  2012-07-01

10.  Analgesic efficacy of oral firocoxib in ovariohysterectomized cats.

Authors:  Prangtip Phuwapattanachart; Naris Thengchaisri
Journal:  J Vet Sci       Date:  2017-06-30       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.